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ense (http://creativecommons.org/Myocardial ischemia during coronary vasospasm may pro-
voke polymorphic ventricular tachycardia (pVT), which, in
some cases, may degenerate into ventricular fibrillation
(VF) and cause sudden cardiac death (SCD)1,2. Although
spontaneous pVT during coronary vasospasm may well be
explained as being triggered by ischemia, its induction
during programmed ventricular stimulation (PVS) has not
been adequately explored, and its association with the
spontaneous occurrence of an arrhythmia remains
dubious. We herein present a case of a patient with
Prinzmetal angina who presented with spontaneous pVT,
and who also had this arrhythmia reproducibly induced
during an electrophysiology study (EPS), which was per-
formed while the patient was under adequate medical
therapy with no clinical or electrocardiographic evidence
of ischemia.
A 74-year-old man with a history of smoking and hyper-
tension presented to his local hospital with typical sub-
sternal chest pain, which had resolved spontaneously after
5 min. The patient described recurrent similar episodes of
pain during the preceding two months. The pain was
related to emotional stress and smoking. His ECG on
admission revealed nonspecific ST-T wave abnormalities
(Figure 1A), and his cardiac troponin was negative. His
echocardiography results were normal. He was admitted tof Hellenic Cardiological Society.
.04.006
cal Society. Publishing services by
licenses/by-nc-nd/4.0/).the cardiology ward and was continuously monitored. Serial
testing for cardiac enzymes was negative. During his hos-
pital stay, he experienced recurrent episodes of angina,
associated with transient ST-segment elevation followed by
non-sustained pVT recorded on telemetry (Figure 1B and
1C).
The patient subsequently underwent coronary angiog-
raphy, which demonstrated atherosclerotic coronary ar-
teries without fixed critical stenoses. However,
spontaneous vasospasm of the left anterior descending
(LAD) and the left circumflex (LCx) coronary arteries was
documented, which was resolved with intracoronary nitro-
glycerin infusion (Figure 2).
With the working diagnosis of vasospastic (Prinzmetal)
angina, coronary vasodilatory therapy with nitrates and
calcium channel blockers was initiated.1 As he had expe-
rienced nonsustained VT, an EPS was recommended and
performed while the patient was undergoing medical
treatment and after he had been asymptomatic for five
days. During the EPS, multiple episodes of non-sustained
pVT were easily induced by PVS with use of two ventric-
ular extrastimuli at the right ventricular apex. In addition,
two of these episodes became sustained and degenerated
into VF, which was electrically cardioverted (Figure 3)
with no accompanying ST-T changes on the ECG; his
electrolytes were normal. These findings prompted the
recommendation for an implantable cardioverter-
defibrillator (ICD) that was subsequently implanted. Six
months later, the patient sustained another coronary
event, albeit without the recurrence of arrhythmia,
attributed to coronary vasospasm; a repeat coronary
angiography was normal, and the medical therapy was
intensified. At the latest follow-up of 18 months, runs of
non-sustained VT that did not trigger the device and an
episode of electromagnetic interference triggering an ICD
shock were documented.Elsevier B.V. This is an open access article under the CC BY-NC-ND
Figure 1 A) Resting 12-lead ECG on admission. B) Rhythm strip showing transient ST-segment elevation during an episode of
angina, followed by non-sustained ventricular tachycardia (VT). C) Spontaneous termination of the same VT episode.
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Figure 2 Coronary angiography demonstrating A) vasospasm
of the LAD and the LCx (paucity of vessels), B) resolution with
intracoronary nitrate infusion. LADZ left anterior descending;
LCx Z left circumflex.
Letter to the Editor 207Patients with Prinzmetal angina usually have a good
prognosis with medical treatment. 1,2 However, some pa-
tients experience SCD due to pVT.2,3 ICD implantation is a
proven therapy for the prevention of SCD.4,5 However, little
research has been done regarding primary prevention of
SCD in patients with vasospastic angina and ventricular
arrhythmias and the efficacy of ICD implantation in such
patients is currently under investigation.6 Most studies have
dealt with patients who are cardiac arrest survivors,
whereby an ICD seems beneficial (Class I recommendation
by the current guidelines),2 but with no reference to pa-
tients with vasospastic angina.5 Regarding the primary
prevention of SCD, there is a Class IIa indication for an ICD
in patients with an uncommon arrhythmogenic condition
whose annual risk of SCD is  3e4%.5 Moreover, inducible
pVT in patients without structural heart disease is not
included as indication for ICD.7
Patients with Prinzmetal angina have high ventricular
vulnerability.8 However, no study has been done to esti-
mate the precise annual risk for cardiac arrest for these
patients, except for retrospective studies with patients
already having an ICD. Nevertheless, the risk stratificationof such patients is crucial. Takagi et al. have developed a
clinical scoring system as an effort to provide risk assess-
ments and prognostic stratifications for these patients.9
However, it is still difficult to distinguish patients who
may respond to medical treatment from those at high risk
for SCD despite optimal medical treatment, as this
distinction cannot be based on the presence or absence of
symptoms.10
We considered our patient as being at high risk for SCD,
as he had experienced symptomatic non-sustained VT and
had many other independent risk factors for adverse car-
diac events.6,10 Therefore, to further evaluate him, we
performed an EPS. During EPS his arrhythmia was easily
inducible without an aggressive protocol and despite un-
dergoing an optimal medical treatment and without
developing clinically and electrocardiographically apparent
coronary vasospasm-induced ischemia, as evidenced by the
fact that the patient experienced no angina during the EPS
and there were no ECG signs of ischemia. Based on all these
results and findings, we implanted an ICD for prevention of
SCD.8 The patient had runs of non-sustained VT at follow-up
but no sustained arrhythmic episodes to date.
To the best of our knowledge, this is the first reported
Prinzmetal angina patient with clinically recurrent epi-
sodes of pVT during coronary vasospasm-induced myocar-
dial ischemia, who subsequently underwent an EPS while
being asymptomatic on an optimal medical therapy to
evaluate for ventricular vulnerability and the need for an
ICD. Furthermore, this is the first patient with documented
vasospastic angina who during EPS had easily and repro-
ducibly inducible sustained episodes of pVT without an
aggressive protocol, despite being clinically asymptomatic
under medical therapy and with no ECG signs of silent
ischemia, finally having an ICD for primary SCD prevention
based on the results of EPS. It appears that some patients
with vasospastic angina continue having ventricular
vulnerability even when their symptoms are well
controlled with medical therapy and an EPS can uncover
such patients and guide further therapy. Although induc-
ible pVT has been considered as a nonspecific arrhythmia,
especially when induced with an aggressive protocol (e.g.,
three extrastimuli at the right ventricular outflow tract), a
reproducibly inducible pVT with only two ventricular
extrastimuli at the right ventricular apex and coupling
intervals > 200 ms could not have been lightly discarded as
a nonspecific finding in this particular case, as EPS repro-
duced the clinical arrhythmia, albeit in the absence of
ischemia or vasospasm. This case highlights a gap in the
literature regarding the management of patients with
Prinzmetal angina, as most patients with acute coronary
syndrome and sudden death commonly have underlying
fixed coronary disease,11,12 whereby an EPS may deter-
mine arrhythmia vulnerability and predict the subsequent
need for ICD therapies.13,14 In conclusion, the important
role of EPS in risk stratification and the indication for an
ICD implantation in patients with Prinzmetal angina needs
to be further addressed in future studies.
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Figure 3 A) Hemodynamically unstable, sustained polymorphic VT, induced during programmed ventricular stimulation at the
right ventricular apex with 2 ventricular extrastimuli at a drive cycle length of 400 ms. B) The same VT episode terminated with DC
shock.
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